Sustained Avastin aids colon cancer survival-study | Reuters.
LOS ANGELES (Reuters) – Colorectal cancer patients who continued treatment with Roche Holding AG’s Avastin even after their cancer worsened lived longer than those who went off the drug, according to an “observational analysis” released on Thursday.
5 responses to “Sustained Avastin aids colon cancer survival-study”
[…] Sustained Avastin aids colon cancer survival-study […]
This is good news! But in some ways, somewhat frustrating too. It’s good to live longer, but who wants to prolong a disease if one has cancer?
greek orthodox…
[…]Sustained Avastin aids colon cancer survival-study | Live Fit and Sore[…]…
I do trust all of the ideas you have presented to your
post. They’re very convincing and will certainly work.
Still, the posts are too quick for starters. Could you please extend them a bit from next time?
Thanks for the post.
I’ve been exploring for a little bit for any high quality articles or blog posts in this kind of house .
Exploring in Yahoo I eventually stumbled upon this site.
Reading this info So i’m happy to express that I have an incredibly good uncanny feeling I
discovered just what I needed. I such a lot unquestionably will make certain to don?t omit this web site and
give it a look regularly.